Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | Lestaurtinib | 0.3 | uM | 3 | MIP-1A | 17.0 | 61 | ||||
N2586 | Ruxolitinib | 0.3 | uM | 3 | MIP-1A | 18.0 | 83 | ||||
N2586 | Tofacitinib | 0.3 | uM | 3 | MIP-1A | 15.0 | 57 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | MIP-1A | 18.5 | 44 | ||||
N2586 | JNK-IN-8 | 3.0 | uM | 3 | MIP-1A | 19.0 | 68 | ||||
RA2159 | IL-17A | 100 | ng/mL | 3 | MIP-1A | 23.0 | 70 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 3 | MIP-1A | 27.5 | 64 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | MIP-1A | 21.0 | 63 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | MIP-1A | 24.5 | 60 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | MIP-1A | 27.0 | 67 | |
RA2159 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 3 | MIP-1A | 21.0 | 66 | |
N2586 | IL-17A | 100 | ng/mL | 3 | MIP-1A | 22.0 | 82 | ||||
N2586 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 3 | MIP-1A | 19.0 | 99 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | MIP-1A | 18.0 | 86 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | MIP-1A | 22.0 | 54 | |
N2586 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | MIP-1A | 21.0 | 80 | |
N2586 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 3 | MIP-1A | 22.0 | 59 | |
RA2159 | IL-6 | 100 | ug/mL | 3 | MIP-1A | 25.0 | 67 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 3 | MIP-1A | 22.0 | 61 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | MIP-1A | 22.0 | 61 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | MIP-1A | 24.0 | 68 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | MIP-1A | 18.0 | 76 | |
RA2159 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 3 | MIP-1A | 21.0 | 77 | |
RA2159 | Sigma A6730 | 3.0 | uM | 3 | MIP-1A | 19.0 | 71 | ||||
N2586 | IL-6 | 100 | ug/mL | 3 | MIP-1A | 21.0 | 87 |